قالب وردپرس درنا توس
Home / World / Serum Institute of India warns of delayed export of vaccines

Serum Institute of India warns of delayed export of vaccines



The CEO of the Indian pharmaceutical giant said on Sunday that dozens of countries are counting on providing it with the Covid-19 vaccine, and their delivery may be delayed because it has been “targeted” Meet domestic demand before export orders.

“Dear country and government,” Adar Poonawalla, an executive at the Serum Institute of India, wrote in a tweet, warning of the delay. He wrote: “I humbly ask you to wait patiently,” he added, adding that his company has been arranged to prioritize “the huge demand in India and take into account the needs of the rest of the world. We are doing our best.”

He did not say who issued the order, and the Serum Institute did not immediately return a request for comment.

India produces three-fifths of the world’s vaccines. The country’s Prime Minister Narendra Modi (Narendra Modi) launched one of the world’s largest and most ambitious vaccination campaigns, aiming to provide India with 13 100 million people are vaccinated.

However, even though India has implemented a huge immunization program, which requires an average of 390 million vaccines for diseases such as measles and tuberculosis each year, India is still working hard to vaccinate the population with Covid. Since mid-January, less than 1% of Indians have been vaccinated. To date, the epidemic has caused at least 10.9 million known coronavirus infections in India, more than any other country except the United States.

The country’s regulatory agencies have approved two vaccines: one developed by AstraZeneca and Oxford University and produced by the Serum Institute, and the other (still in trials) by the National Institute of Virology and the local pharmaceutical company Barra Jointly developed by special biotech companies.

Once approved, the Serum Institute will also produce a vaccine developed by Novartis Vaccine.

In addition to helping India and other customers, the company is also expected to produce hundreds of millions of doses of AstraZeneca vaccines and more than one billion Novovax vaccines, which will be distributed through the global vaccination program Covax, aiming to ensure that 92 low- and middle-income countries are 98 wealthy countries in the world receive vaccination at the same time. Kovacs did not immediately respond to a request for comment regarding Mr. Poonawalla’s warning that foreign countries must wait for the vaccine.

Many developing countries want to use the AstraZeneca vaccine because it is much cheaper than other Covid vaccines currently in use and is easy to store and transport. This also makes it suitable for India’s mass vaccination campaign, which must go from the towering Himalayas to the dense jungles of southern India.

Competing with China, the Indian government is increasingly using the country’s vaccine production capacity as its international diplomatic currency, which makes shots the center of its diplomatic relations. For example, last week India pledged to donate 200,000 doses of vaccine to United Nations peacekeepers around the world.




Source link